Current Medicinal Chemistry
Title:Meet Our Editorial Board Member
Volume: 22 Issue: 20
Author(s): James David Adams
Affiliation:
Export Options
About this article
Cite this article as:
Adams David James, Meet Our Editorial Board Member, Current Medicinal Chemistry 2015; 22 (20) . https://dx.doi.org/10.2174/092986732220150722123132
DOI https://dx.doi.org/10.2174/092986732220150722123132 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
23
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hypertension in Chronic Kidney Disease: Novel Insights
Current Hypertension Reviews Is Hyperhomocyst(e)inemia A Humoral Predictor of Coronary Heart Disease?
Current Pharmaceutical Design High Throughput Screening for Colorectal Cancer Specific Compounds
Combinatorial Chemistry & High Throughput Screening Upon the Developments of Drug-Eluting Stents in the Treatment of Coronary Lesions
Recent Patents on Materials Science Pleiotropic Effects of ARB in Metabolic Syndrome
Current Vascular Pharmacology Social Media Use in Cardiovascular Imaging
Current Cardiology Reviews Phase Transition System: Novel Oral In-Situ Gel
Current Drug Delivery Meet Our Editorial Board Member
Cardiovascular & Hematological Agents in Medicinal Chemistry Endothelium Dependent and Independent Mechanisms of Vasorelaxant Activity of Synthesized 2,5-disubstituted-1,3,4-oxadiazole Derivatives in Rat Thoracic Aorta – Ex vivo and Molecular Docking Studies
Letters in Drug Design & Discovery Impact of Aging on the Angiogenic Potential of the Myocardium: Implications for Angiogenic Therapies with Emphasis on Sirtuin Agonists
Recent Patents on Cardiovascular Drug Discovery Old Weapons for New Wars: Bioactive Molecules From Cnidarian Internal Defense Systems
Central Nervous System Agents in Medicinal Chemistry Open Questions about Pulmonary Hypertension and Exercise Training: A Critical Review
Current Respiratory Medicine Reviews Use of Recombinant Factor VII in Cardiac Surgery
Recent Patents on Cardiovascular Drug Discovery Therapies Targeting Inflammation After Stent Implantation
Current Vascular Pharmacology Adenosine A1 Receptors in the Central Nervous System: Their Functions in Health and Disease, and Possible Elucidation by PET Imaging
Current Medicinal Chemistry Towards the Management of Inflammation: Recent Developments of mPGES-1 Inhibitors
Recent Patents on CNS Drug Discovery (Discontinued) ACKNOWLEDGEMENTS TO REVIEWERS
Current Hypertension Reviews HGF as Angiogenic Factor and Therapeutic Approach
Current Signal Transduction Therapy Intracoronary Brachytherapy - Clinical State and Pathophysiological Considerations
Current Pharmaceutical Design Platelet Resistance to Antiplatelet Drugs
Recent Patents on Cardiovascular Drug Discovery